证券记录 · 已归档季度
INCY
Incyte Corporation · Healthcare · Biotechnology
19被追踪持有人
+1Δ持有人
43.85M持有股份
$3.03B报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +5.6% ·
股份流向 -3.7% ·
净新建仓位 +5.3%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 433.49K | $48.73M | n/a | −2 |
| Q2 2026 | 154 | 0 | 131.73M | $14.93B | +4 | −5 |
| Q1 2026 | 158 | +1 | 132.61M | $12.47B | +5 | −5 |
| Q4 2025 | 156 | -1 | 139.13M | $13.74B | +1 | −1 |
| Q3 2025 | 24 | 0 | 89.63M | $7.60B | n/a | −1 |
| Q2 2025 | 22 | +1 | 88.20M | $6.01B | +1 | n/a |
| Q1 2025 | 18 | -1 | 44.33M | $2.68B | n/a | −1 |
| Q4 2024 | 19 | +1 | 43.85M | $3.03B | +1 | n/a |
| Q3 2024 | 17 | 0 | 35.50M | $2.35B | +1 | −1 |
| Q2 2024 | 17 | n/a | 33.47M | $2.03B | n/a | n/a |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 14.92M | -2.3% | $1.03B | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (被动) | 10.03M | n/a | $692.82M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 4.09M | -9.2% | $282.22M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 4.04M | +2.6% | $278.35M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | AQR Capital Management ✦ | 3.50M | +29.6% | $241.52M | 0.3% | ▲ Add | 3 | SEC ↗ ×5 |
| 6 | Norges Bank ✦ (被动) | 1.76M | +4.8% | $121.89M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 1.28M | -46.0% | $88.30M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 913.71K | +50.2% | $63.11M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | Bridgewater Associates ✦ | 671.78K | +117.7% | $46.40M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 10 | Marshall Wace ✦ | 585.72K | -54.2% | $40.46M | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 11 | D. E. Shaw & Co. ✦ | 576.54K | -48.0% | $39.82M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 12 | Millennium Management ✦ | 545.95K | -3.4% | $37.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 268.76K | 新增 | $18.56M | 0.0% | New | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 229.87K | -70.6% | $15.88M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | ARK Investment Management ✦ | 161.78K | -23.5% | $11.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 136.36K | +90.1% | $9.42M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 77.31K | +18.2% | $5.34M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 28.92K | +151.0% | $2.00M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 28.05K | +36.3% | $1.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Arrowstreet Capital | $18.56M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 805 持有人, 201.47M 股份, $18.13B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 15
CAGNONI PABLO J
Officer · 2.64K 股 · $297,780
Sep 15
CAGNONI PABLO J
Officer · 13.98K 股 · $1.69M
Sep 15
CAGNONI PABLO J
Officer · 9.23K 股 · $1.11M
Aug 19
CAGNONI PABLO J
Officer · 10.80K 股 · $1.36M
Aug 12
CAGNONI PABLO J
Officer · 10.80K 股 · $1.30M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据